1. Anthracycline-Free Neoadjuvant Chemotherapy Ensures Higher Rates of Pathologic Complete Response in Breast Cancer
   Francesca De Iuliis et al, 2017, Clinical Breast Cancer CrossRef
2. CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy
   Rachel L. Mintz et al, 2018, Advanced Biosystems CrossRef
3. Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review
   Jessa Gilda P. Pandy et al, 2019, BMC Cancer CrossRef
4. Treatment with Cisplatin and Etoposide Chemotherapy in Patient with Metastatic Breast Cancer
   Mi Kim et al, 2017, Journal of Breast Disease CrossRef
5. Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification
   Fouzia Guestini et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
6. Anticancer activity of RAPTA-EA1 in triple-negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib
   Khwanjira Hongthong et al, 2021, Heliyon CrossRef
7. Cancer of the Breast: An Overview
   Frederick O. Stephens et al, 2016, Basics of Oncology CrossRef
8. Novel therapeutic strategies in the treatment of triple-negative breast cancer
   Karima Oualla et al, 2017, Therapeutic Advances in Medical Oncology CrossRef
9. The water soluble ruthenium(II) organometallic compound [Ru( p -cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells
   Maura Montani et al, 2016, Pharmacological Research CrossRef
10. Induction Chemotherapy for Breast Cancer
    François-Michel Delgado et al, 2016, Induction Chemotherapy CrossRef